Skip to content
Cover image for insulin resistance and stem cells

Insulin resistance and metabolic syndrome: where cell therapy fits

Waistline, blood pressure, lipids and glucose as one problem

Quick answer

Metabolic syndrome is a cluster — excess waist circumference, high blood pressure, high triglycerides, low HDL and elevated glucose — with insulin resistance at its centre. The MSC rationale is to reduce the chronic inflammation linking them, always alongside weight loss and exercise.

Key facts

Core driver
Insulin resistance
Values to track
HOMA-IR, HbA1c, hs-CRP
Key mediators
TNF-alpha, IL-6
Foundation
Weight loss and exercise

Visceral fat as an inflammatory organ

Visceral fat is not inert tissue: it releases inflammatory mediators such as TNF-alpha and IL-6 that interfere with insulin signalling in muscle and liver. That is why losing even a few centimetres of waistline shifts glucose numbers.

Values to measure before and after

MSC studies here track HOMA-IR, HbA1c, triglycerides and hs-CRP. Without before-and-after values it is impossible to tell whether any change came from the therapy or from the lifestyle adjustments made at the same time.

Beware anti-ageing packages without labs

If you are looking at anti-ageing programmes in Korea, be wary of cell therapy sold as a beauty package with no baseline blood work. A credible programme starts with a systematic metabolic assessment.

Frequently asked questions

  • Do you have to be obese to be insulin resistant?

    No — lean people with high visceral fat can be affected, so read waistline and blood work together.

  • How long do results last?

    Without behaviour change, the numbers usually drift back.

Share this page

Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.

Back to categories

Related topics: Diabetes & wounds

See all in this category